logo
Select company
Select metric
$ -38.84MConsolidated Income
VS
Market
22
Sector
44
Industry
56
History
74
$ 7.67Close
$ 4.25 - $ 27.58 52-Week Range
Ticker Information

Ticker

LYRA

Company Name

LYRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYRA THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYRA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -38.84M
3/31/2025$ -79.53M
12/31/2024$ -93.44M
9/30/2024$ -97.61M
6/30/2024$ -101.39M
3/31/2024$ -68.88M
12/31/2023$ -62.68M
9/30/2023$ -61.76M
6/30/2023$ -60.87M
3/31/2023$ -59.62M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYRA THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -22.13M.
  • Over the past 5 years, LYRA THERAPEUTICS INC's average Cons. Inc. has been $ -57.05M.
  • The median Cons. Inc. for LYRA THERAPEUTICS INC during this period was $ -55.28M
  • LYRA THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -22.13M.
  • The lowest Cons. Inc. recorded by LYRA THERAPEUTICS INC in the same timeframe $ -101.39M

LYRA THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
APRE : APREA THERAPEUTICS INC $ -13.85MBRTX : BIORESTORATIVE THERAPIES INC $ -10.72MERNA : ERNEXA THERAPEUTICS INC $ -43.7MVYNE : VYNE THERAPEUTICS INC $ -38.55MSXTP : 60 DEGREES PHARMACEUTICALS INC $ -7.82MLEXX : LEXARIA BIOSCIENCE CORP $ -11.4MICU : SEASTAR MEDICAL HOLDING CORP $ -14.67MRLYB : RALLYBIO CORP $ -41.65MIBIO : IBIO INC $ -18.38MCODX : CO-DIAGNOSTICS INC $ -35.99M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

LYRA - Consolidated Income, Last 5 years

$ -101.39M

Minimum

Jun 30, 2024

$ -22.13M

Maximum

Dec 31, 2020

$ -57.05M

Average

$ -55.28M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M